ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jul 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
September 2026
Nuclear Technology
August 2026
Fusion Science and Technology
Latest News
Texas A&M welcomes uranium conversion research
The Texas A&M Engineering Experiment Station (TEES) has signed a research agreement with Quantum Leap Energy (QLE) “to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6).”
QLE is an Austin, Texas–based subsidiary of ASP Isotopes (ASPI), which is developing an isotope enrichment platform for applications in nuclear energy, nuclear medicine, and semiconductors. QLE specializes in the uranium conversion step of the nuclear fuel cycle—the conversion of yellowcake uranium concentrate (U3O8) into UF6 prior to enrichment.
Anthony W. LaPorta
Nuclear Technology | Volume 205 | Number 10 | October 2019 | Pages 1290-1301
Technical Paper | doi.org/10.1080/00295450.2019.1565471
Articles are hosted by Taylor and Francis Online.
The Transient Reactor Test (TREAT) facility was constructed in 1958 and became operational in 1959. The TREAT reactor is an air-cooled test reactor that can be operated in multiple modes: up to 20 GW for short-duration “burst” pulses (approximately 100 to 200 ms) producing an intense neutron pulse; lower power (megawatt range)–shaped transients intended to simulate fuel heating prior to accident conditions being imposed; or in a low power mode of up to 120 kW for experiment preconditioning or neutron radiography. TREAT operated from 1959 through 1994 when it was put into a standby condition. With the accident at Fukashima-Daiichi that resulted in extensive fuel failure, the U.S. Department of Energy selected TREAT for restart and irradiation of new accident-tolerant fuel designs for U.S. commercial nuclear plants. This paper discusses the basic process that was used to perform the initial criticality following the TREAT extended shutdown operation from 1994 to 2017.